Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

Researchers developed a scalable framework that predicts insulin resistance using wearable-device signals, routine blood biomarkers, and demographic data, with stronger performance when these data ...

Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced the publication of 48-week results from its REGENT-1 Australia ...

The latest cholesterol guidelines include three new screening tests: coronary artery calcium, lipoprotein (a), and apolipoprotein B.

When combined with clinical markers, smartwatch data was able to help detect insulin resistance with nearly 90 percent ...

Sana Biotechnology’s investigational allogeneic islet cell therapy has survived and secreted insulin for more than one year ...

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the ...

A major study by smart ring and CGM maker Ultrahuman highlights patterns between when you go to sleep and elevated blood ...